Machine Learning Technology for Evaluation of Liver Fibrosis, Inflammation Activity and Steatosis (LIVERFASt™)

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease

PubMed: 26181592
DOI: 10.1371/journal.pone.0131707

Comparison of 16 blood and/or elastometric fibrosis tests in 5 causes of chronic liver diseases: too much? Towards a simplification

Direct Comparisons of Fibrotest, APRI, FIB-4, and Transient Elastography (TE) for the diagnosis of cirrhosis and fibrosis, in patients with chronic Hepatitis C (CHC) and B (CHB) using intention to diagnose and Bayesian methods. A systematic review

Liver Fibrosis Epidemiology Revisited Using Software Combined Biomarker: Proof of Concept Using 1,081,658 Centralised Fibrotest (FT) Prescriptions